Cargando…
SPIDR: small-molecule peptide-influenced drug repurposing
BACKGROUND: Conventional de novo drug design is costly and time consuming, making it accessible to only the best resourced research organizations. An emergent approach to new drug development is drug repurposing, in which compounds that have already gone through some level of clinical testing are ex...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902895/ https://www.ncbi.nlm.nih.gov/pubmed/29661129 http://dx.doi.org/10.1186/s12859-018-2153-y |